More than 85 percent of African-American men and women are likely to develop hypertension in their lifetimes based on the new cutoff for high blood pressure established in the 2017 U.S. guidelines, researchers reported March 27 in JAMA Cardiology.
A U.S. radiologist with a long, distinguished career that launched after a remarkable move from Korea has caught the eye of a National Public Radio affiliate in Buffalo, New York.
A study published in Radiology on March 26 suggests rapid short-pulse ultrasound is as effective—and maybe more so—than standard and long-pulse therapy for delivering drugs across the blood-brain barrier.
A new AI software can quickly and accurately determine the manufacturer and model of a cardiac rhythm device from an x-ray, possibly speeding up treatment when the devices fail.
Researchers have established normal ranges of bone density in a part of the lumbar spine that is routinely imaged incidentally. Their primary aim is to equip radiologists with data that can be referred to when reading chest and abdominal CTs so the reader can opportunistically cross-screen for osteoporosis and check for compression fractures.
An AI model developed by a startup in Kentucky is analyzing insurance claims databases to flag expectant mothers at the greatest risk of giving birth to a preterm baby, Wired reported March 26.
The average annual compensation for radiologists in the United States is $429,000, according to a new report from Doximity. Radiology was ranked 10th among all specialties included in the report.
CMS has launched an AI challenge that’s incentivizing innovators to develop solutions for a range of administrative challenges, like predicting unplanned hospital admissions and adverse events, the agency announced March 27.
Medicare fee-for-service (FFS) programs racked up an estimated $23.2 billion in improper payments in 2017, according to CMS data—almost $19 billion more than Medicaid FFS’ $4.3 billion and a red flag that the program’s documentation requirements might not be up to par.
Nearly 60 percent of patients who met guideline-based criteria for statin therapy but weren’t taking the cholesterol-lowering drugs said they were never offered one, according to a study published March 27 in the Journal of the American Heart Association.
